220 related articles for article (PubMed ID: 16949075)
21. Intracellular efficacy of tumor-targeting group I intron-based trans-splicing ribozyme.
Kwon BS; Jeong JS; Won YS; Lee CH; Yoon KS; Hyung Jung M; Kim IH; Lee SW
J Gene Med; 2011 Feb; 13(2):89-100. PubMed ID: 21322101
[TBL] [Abstract][Full Text] [Related]
22. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
Hong SH; Jeong JS; Lee YJ; Jung HI; Cho KS; Kim CM; Kwon BS; Sullenger BA; Lee SW; Kim IH
Mol Ther; 2008 Jan; 16(1):74-80. PubMed ID: 17700543
[TBL] [Abstract][Full Text] [Related]
23. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
Plumb JA; Bilsland A; Kakani R; Zhao J; Glasspool RM; Knox RJ; Evans TR; Keith WN
Oncogene; 2001 Nov; 20(53):7797-803. PubMed ID: 11753658
[TBL] [Abstract][Full Text] [Related]
24. Cancer-specific induction of adenoviral E1A expression by group I intron-based trans-splicing ribozyme.
Won YS; Lee SW
J Microbiol Biotechnol; 2012 Mar; 22(3):431-5. PubMed ID: 22450801
[TBL] [Abstract][Full Text] [Related]
25. [Hammerhead ribozyme against human telomerase catalytic subunit (hTERT) induced apoptosis of liver cancer cells].
Song DP; Lin JS; Fu GL; Sun XM; Kong XJ; Li PY; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):616-9. PubMed ID: 15504295
[TBL] [Abstract][Full Text] [Related]
26. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
[TBL] [Abstract][Full Text] [Related]
27. [Attenuation of telomerase activity by hammerhead ribozyme targeting the 5'-end of hTERT mRNA].
Qu Y; Liu S; Liu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):389-92. PubMed ID: 12362313
[TBL] [Abstract][Full Text] [Related]
28. Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells.
Kim SJ; Lee HS; Shin JH; Kim CG; Jeong S; Park K; Choe H; Lee H
Oncol Rep; 2006 Nov; 16(5):975-9. PubMed ID: 17016580
[TBL] [Abstract][Full Text] [Related]
29. [Construction of an expression vector under the control of hTERT promoter].
Han MK; Zhang HZ; Cheng SY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):384-6. PubMed ID: 15862165
[TBL] [Abstract][Full Text] [Related]
30. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
[TBL] [Abstract][Full Text] [Related]
31. [Construction of a trans-splicing ribozyme for restoring EGFP truncation mutation].
Li B; Xiong YQ; Tu HB; Liu QC; Zou DT; Zhou WQ; Chen YY
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):748-53. PubMed ID: 16285516
[TBL] [Abstract][Full Text] [Related]
32. Selective expression of transgene using hypoxia-inducible trans-splicing group I intron ribozyme.
Kim SJ; Lee SW
J Biotechnol; 2014 Dec; 192 Pt A():22-7. PubMed ID: 25312327
[TBL] [Abstract][Full Text] [Related]
33. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T
Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487
[TBL] [Abstract][Full Text] [Related]
34. Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells.
Abdul-Ghani R; Ohana P; Matouk I; Ayesh S; Ayesh B; Laster M; Bibi O; Giladi H; Molnar-Kimber K; Sughayer MA; de Groot N; Hochberg A
Mol Ther; 2000 Dec; 2(6):539-44. PubMed ID: 11124054
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
36. [Construction and screening of a ribozyme targeting telomerase RNA and effects of telomerase ribozyme on proliferation and apoptosis of CNE-2Z cells].
Zhao YH; Chen XY; R Arrand J
Ai Zheng; 2004 Jan; 23(1):50-5. PubMed ID: 14720374
[TBL] [Abstract][Full Text] [Related]
37. Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.
Bilsland AE; Merron A; Vassaux G; Keith WN
Cancer Res; 2007 Feb; 67(3):1299-307. PubMed ID: 17283167
[TBL] [Abstract][Full Text] [Related]
38. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
[TBL] [Abstract][Full Text] [Related]
39. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
[TBL] [Abstract][Full Text] [Related]
40. Single-cell detection of trans-splicing ribozyme in vivo activity.
Hasegawa S; Choi JW; Rao J
J Am Chem Soc; 2004 Jun; 126(23):7158-9. PubMed ID: 15186136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
